Envafolimab Plus Chemoradiotherapy for Locally Advanced NPC, a Prospective, Single Armed Phase II Trial.

Clinical trial NCT05397769 · RECRUITING

Trial details

NCT number: NCT05397769
Sponsor: Sun Yat-sen University
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Locally Advanced Nasopharyngeal Carcinoma Envafolimab Induction Chemotherapy PD-L1

Start date: 2022-06-08
Primary completion: 2026-06-01
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.